The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen
Incidence, mitigation, and management of neurologic adverse events in patients with multiple myeloma (MM) treated with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-2.
 
Hermann Einsele
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb; Celgene (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda; Takeda
 
Samir S. Parekh
No Relationships to Disclose
 
Deepu Madduri
Honoraria - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Kinevant; Legend Biotech; Sanofi; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Kinevant; Legend Biotech; Sanofi; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Regeneron
 
Bianca Santomasso
Consulting or Advisory Role - Celgene; Janssen; Legend Biotech
Research Funding - ADC Therapeutics (Inst)
 
Jaime Gállego Pérez De Larraya
Consulting or Advisory Role - Janssen
Speakers' Bureau - Eisai Europe
Research Funding - DNAtrix (Inst)
 
Niels W.C.J. van de Donk
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Cellectis (Inst); Janssen (Inst); Novartis (Inst)
 
Bertrand Arnulf
Honoraria - Celgene; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag
Research Funding - Janssen-Cilag
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen-Cilag; Takeda
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Adaptive Biotechnologies; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Roche/Genentech; Takeda
 
Kevin C. De Braganca
Employment - Janssen Research & Development
 
Helen Varsos
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
Travel, Accommodations, Expenses - Janssen Research & Development
 
Marlene Carrasco-Alfonso
Employment - Legend Biotech; Novartis
Stock and Other Ownership Interests - Abeona Therapeutics; Adaptimmune; Adverum; Akcea Therapeutics; Allogene Therapeutics; Alnylam; Arbutus Biopharma; Arrowhead Pharmaceuticals; Atara Biotherapeutics; Audentes Therapeutics; Legend Biotech; Novartis
 
Muhammad Akram
Employment - Legend Biotech
Stock and Other Ownership Interests - Legend Biotech
Research Funding - Legend Biotech
Travel, Accommodations, Expenses - Legend Biotech
Other Relationship - Legend Biotech
 
Nikoletta Lendvai
No Relationships to Disclose
 
Carolyn Chang Jackson
Employment - Janssen Research & Development
Consulting or Advisory Role - Memorial Sloan-Kettering Cancer Center
 
Yunsi Olyslager
No Relationships to Disclose
 
Enrique Zudaire
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
Patents, Royalties, Other Intellectual Property - Patents pending with Janssen
Travel, Accommodations, Expenses - Janssen Research & Development
 
Claire Li
Patents, Royalties, Other Intellectual Property - Merck
Travel, Accommodations, Expenses - Merck
 
Dong Geng
Employment - Legend Biotech
Stock and Other Ownership Interests - Legend Biotech
Research Funding - Legend Biotech
Expert Testimony - Legend Biotech (I)
Travel, Accommodations, Expenses - Legend Biotech
 
Andrzej J. Jakubowiak
Leadership - Membership on an entity's Board of Directors or advisory committees (AbbVie, Amgen, BMS/Celgene, GSK, Janssen, Karyopharm, Sanofi
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Sanofi
 
Adam D. Cohen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Genentech/Roche; GlaxoSmithKline; Janssen; Takeda
Patents, Royalties, Other Intellectual Property - Novartis